Bio-Rad Laboratories, Inc. (BIO.B)

NYSE: BIO.B · Real-Time Price · USD

268.50

-13.45 (-4.77%)

At close: Mar 9, 2026, 4:00 PM EDT

268.50

0.00 (0.00%)

After-hours: Mar 9, 2026, 7:00 PM EDT

Bio-Rad Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	529.8	488.1	403.8	434.22	470.78
Short-Term Investments	1,011	1,176	1,209	1,362	404.7
Cash & Short-Term Investments	1,541	1,665	1,613	1,796	875.48
Cash Growth	-7.44%	3.21%	-10.22%	105.17%	-12.16%
Accounts Receivable	460.6	452.5	489	494.65	423.54
Inventory	740.7	760	780.5	719.32	572.24
Other Current Assets	164.2	153.3	166.1	147.78	119.23
Total Current Assets	2,906	3,030	3,048	3,158	1,990
Net Property, Plant & Equipment	709.9	688.6	723.7	679.56	716.44
Other Intangible Assets	174.3	293.6	320.5	332.15	253.94
Goodwill	579.8	410.5	413.6	406.49	347.34
Long-Term Investments	6,104	4,839	7,698	8,831	14,387
Other Long-Term Assets	102.7	101.9	94.9	94.6	104.19
Total Assets	10,577	9,364	12,299	13,502	17,799
Accounts Payable	129	122.3	144.6	135.04	141.94
Accrued Expenses	172.3	124.2	139.9	194.79	276.99
Current Portion of Long-Term Debt	1.3	1.2	0.5	0.47	0.49
Current Portion of Leases	36.1	41.7	40.4	36.34	36.44
Unearned Revenue	-	-	-	-	50.85
Other Current Liabilities	178.3	178.4	197.4	202.08	174.24
Total Current Liabilities	517	467.8	522.8	568.71	680.94
Long-Term Debt	1,202	1,200	1,199	1,198	10.51
Long-Term Leases	145.7	131.4	165.5	153.6	175.94
Other Long-Term Liabilities	1,259	995.2	1,671	1,966	3,247
Total Long-Term Liabilities	2,606	2,327	3,035	3,318	3,433
Total Liabilities	3,123	2,795	3,558	3,886	4,114
Common Stock	-	-	-	0	0
Treasury Stock	-1,010	-772.1	-632.5	-263.59	-106.29
Additional Paid-in Capital	476	463.2	449.1	447.45	441.73
Accumulated Other Comprehensive Income	-189.1	-538.2	-336	-466.82	-175.55
Retained Earnings	8,176	7,416	9,261	9,898	13,525
Shareholders' Equity	7,454	6,569	8,741	9,615	13,685
Total Liabilities & Equity	10,577	9,364	12,299	13,502	17,799
Total Debt	1,385	1,375	1,406	1,388	223.38
Net Cash (Debt)	155.9	289.8	207.2	408.12	652.1
Net Cash Growth	-46.20%	39.87%	-49.23%	-37.41%	-15.42%
Net Cash Per Share	5.71	10.27	7.09	13.70	21.59
Book Value	7,454	6,569	8,741	9,615	13,685
Book Value Per Share	273.22	232.84	299.26	322.82	453.03
Tangible Book Value	6,700	5,865	8,007	8,877	13,084
Tangible Book Value Per Share	245.57	207.88	274.13	298.02	433.13

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q